On this page
Sterile Water
Water · Injection
Overview
Active ingredients
Source: NDC Directory| Ingredient | Strength | RxCUI | Monograph |
|---|---|---|---|
| Water | 1 mL/mL | 1053154 | View |
Forms, strengths and routes
Source: NDC DirectoryRegulatory status
Source: Drugs@FDANDC Directory| Product | Trade name | Form | Strength | Ingredient | Status | TE | Flags |
|---|---|---|---|---|---|---|---|
| 018801-001 | STERILE WATER FOR INJECTION | LIQUID | STERILE WATER FOR INJECTION | Discontinued | — | RLD | |
| 018801-002 | STERILE WATER FOR INJECTION | LIQUID | STERILE WATER FOR INJECTION | Prescription | AP | RLD RS | |
| 018801-003 | STERILE WATER FOR INJECTION | LIQUID | STERILE WATER FOR INJECTION | Prescription | AP | RLD RS | |
| 018801-004 | STERILE WATER FOR INJECTION | LIQUID | STERILE WATER FOR INJECTION | Prescription | — | RLD RS | |
| 018801-005 | STERILE WATER FOR INJECTION | LIQUID | STERILE WATER FOR INJECTION | Prescription | — | RLD RS | |
| 018801-006 | STERILE WATER FOR INJECTION | LIQUID | STERILE WATER FOR INJECTION | Prescription | — | RLD RS |
Therapeutic equivalence
Source: Orange BookWhat this rating means: Therapeutically equivalent — bioequivalence demonstrated (parenteral aqueous solutions)
Codes beginning with “A” indicate products the FDA considers therapeutically equivalent. Codes beginning with “B” indicate bioequivalence has not been established. See methodology.
Approval history
Source: Drugs@FDA| Type | No. | Action | Status | Date | Review |
|---|---|---|---|---|---|
| Supplement | 40 | Manufacturing (CMC) | Approved | December 21, 2016 | Standard |
| Supplement | 39 | Manufacturing (CMC) | Approved | March 29, 2016 | Standard |
| Supplement | 36 | Manufacturing (CMC) | Approved | August 1, 2014 | Standard |
| Supplement | 38 | Manufacturing (CMC) | Approved | June 12, 2014 | Standard |
| Supplement | 34 | Manufacturing (CMC) | Approved | July 2, 2009 | Standard |
| Supplement | 23 | Manufacturing (CMC) | Approved | April 7, 2004 | Standard |
| Supplement | 20 | Manufacturing (CMC) | Approved | February 16, 2001 | Standard |
| Supplement | 18 | Manufacturing (CMC) | Approved | June 16, 2000 | Standard |
| Supplement | 19 | Manufacturing (CMC) | Approved | May 4, 2000 | Standard |
| Supplement | 15 | Manufacturing (CMC) | Approved | August 31, 1999 | Standard |
| Supplement | 17 | Manufacturing (CMC) | Approved | May 28, 1999 | Standard |
| Supplement | 16 | Manufacturing (CMC) | Approved | May 27, 1999 | Standard |
| Supplement | 14 | Manufacturing (CMC) | Approved | August 14, 1998 | Standard |
| Supplement | 13 | Labeling | Approved | May 13, 1998 | Standard |
| Supplement | 11 | Manufacturing (CMC) | Approved | January 17, 1997 | Standard |
| Supplement | 12 | Manufacturing (CMC) | Approved | August 29, 1996 | Standard |
| Supplement | 10 | Manufacturing (CMC) | Approved | April 17, 1996 | Standard |
| Supplement | 8 | Manufacturing (CMC) | Approved | June 14, 1989 | Standard |
| Supplement | 7 | Manufacturing (CMC) | Approved | October 21, 1988 | Standard |
| Supplement | 6 | Manufacturing (CMC) | Approved | August 7, 1985 | Standard |
| Supplement | 4 | Manufacturing (CMC) | Approved | March 15, 1985 | Standard |
| Supplement | 5 | Manufacturing (CMC) | Approved | October 22, 1984 | Standard |
| Supplement | 2 | Manufacturing (CMC) | Approved | June 14, 1984 | Standard |
| Supplement | 1 | Manufacturing (CMC) | Approved | January 25, 1984 | Standard |
| Supplement | 3 | Manufacturing (CMC) | Approved | January 17, 1984 | Standard |
| Original application | 1 | Type 5 - New Formulation or New Manufacturer | Approved | October 27, 1982 | Standard |
Prescribing information
Source: openFDA Drug LabelingReproduced verbatim from the Structured Product Labeling submitted to the FDA (effective 20251022). This is the manufacturer's labelling text, not a summary and not advice.
Indications and Usage
openFDA Drug LabelingINDICATIONS AND USAGE Sterile Water for Irrigation is indicated for use as an irrigating fluid or pharmaceutic aid. Sterile Water may also be used as an adjunct in the preparation of non-intravenously administered nutrient mixtures (see DOSAGE AND ADMINISTRATION ).
Dosage and Administration
openFDA Drug LabelingDOSAGE AND ADMINISTRATION This solution is for intravenous use only after admixture or dilution. Do not inject until made approximately isotonic by addition of appropriate solute. Following suitable admixture of prescribed drugs, the dosage is usually dependent upon the age, weight and clinical condition of the patient as well as laboratory determinations. See directions accompanying drugs. The dosage and administration of Sterile Water for Injection USP is dependent upon the recommended dosage and administration of the solute used. Fluid administration should be based on calculated maintenance or replacement fluid requirements for each patient. Some additives may be incompatible. Consult with pharmacist. When performing admixture or dilution, use aseptic techniques. Mix thoroughly. Do not store. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.
Contraindications
openFDA Drug LabelingCONTRAINDICATIONS Sterile Water for Injection, USP must be made approximately isotonic prior to use.
Warnings
openFDA Drug LabelingWARNINGS This solution is for compounding only, not for direct infusion. Hypotonic and hemolytic. Do not inject until made approximately isotonic by addition of an appropriate solute, due to the possibility of hemolysis. The administration of intravenous solutions can cause fluid and/or solute overload resulting in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema. The risk of dilutional states is inversely proportional to the electrolyte concentration. WARNING: This product contains aluminum that may be toxic. Aluminum may reach toxic levels with prolonged parenteral administration if kidney function is impaired. Premature neonates are particularly at risk because their kidneys are immature, and they require large amounts of calcium and phosphate solutions, which contain aluminum. Research indicates that patients with impaired kidney function, including premature neonates, who receive parenteral levels of aluminum at greater than 4 to 5 mcg/kg/day accumulate aluminum at levels associated with central nervous system and bone toxicity. Tissue loading may occur at even lower rates of administration.
Adverse Reactions
openFDA Drug LabelingADVERSE REACTIONS Refer to the package insert of the solute used. Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia. The physician should also be alert to the possibility of adverse reactions to drug additives. Prescribing information for drug additives to be administered in this manner should be consulted. If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.
Drug Interactions
openFDA Drug LabelingDrug Interactions Some drugs for injection may be incompatible in a given vehicle, or when combined in the same vehicle or in a vehicle containing benzyl alcohol. Consult with pharmacist, if available. Use aseptic technique for single or multiple entry and withdrawal from all containers. When diluting or dissolving drugs, mix thoroughly and use promptly. Do not store reconstituted solutions of drugs for injection unless otherwise directed by the manufacturer of the solute. Do not use unless the solution is clear and seal intact. Do not reuse single-dose containers. Discard unused portion.
Description
openFDA Drug LabelingDESCRIPTION Sterile Water for Injection USP is a clear, colorless, odorless liquid. It is sterile, hypotonic, nonpyrogenic, and contains no bacteriostatic or antimicrobial agents. Sterile Water for Injection USP is a diluent or solvent suitable for intravascular injection after first having been made approximately isotonic by the addition of suitable solute. pH: 5.5 (5.0–7.0) Not made with natural rubber latex, PVC or DEHP. The plastic container is made from a multilayered film specifically developed for parenteral drugs. It contains no plasticizers and exhibits virtually no leachables. The solution contact layer is a rubberized copolymer of ethylene and propylene. The container is nontoxic and biologically inert. The container-solution unit is a closed system and is not dependent upon entry of external air during administration. The container is overwrapped to provide protection from the physical environment and to provide an additional moisture barrier when necessary. Addition of medication should be accomplished using complete aseptic technique. The closure system has two ports; the one for the administration set has a tamper evident plastic protector and the other is a medication addition site. Refer to the Directions for Use of the container.
Overdosage
openFDA Drug LabelingOVERDOSAGE Overdosage (hypotonic expansion) is a function of an increase in fluid intake over fluid output, and occurs when the increase in the volume of body fluids is due to water alone. Overdosage may occur in patients who receive large quantities of electrolyte-free water to replace abnormal excessive fluid losses, in patients whose renal tolerance to water loads is exceeded, or in patients who retain water postoperatively in response to stress. Manifestations of water intoxication are behavioral changes (confusion, apathy, disorientation and attendant hyponatremia), central nervous system disturbances (weakness, muscle twitching, headaches, nausea, vomiting, convulsions) and weight gain. Treatment consists of withholding fluids until excessive water is excreted. In severe hyponatremia it may be necessary to cautiously administer hypertonic saline to increase extracellular osmotic pressure and excretion of excess water by the kidneys.
How Supplied / Storage and Handling
openFDA Drug LabelingHOW SUPPLIED Sterile Water for Injection, USP is supplied in the following: Store at 20 to 25C (68 to 77F). [See USP Controlled Room Temperature.] Product repackaged by: Henry Schein, Inc., Bastian, VA 24314 From Original Manufacturer/Distributor's NDC and Unit of Sale To Henry Schein Repackaged Product NDC and Unit of Sale Total Strength/Total Volume (Concentration) per unit NDC 0409-4887-10 Tray of 25 Single-Dose Plastic Fliptop Vials NDC 0404-9959-10 1 10 mL Single-Dose Plastic Fliptop Vial in a bag (Vial bears NDC 0409-4887-17) 10 mL NDC 0409-4887-20 Tray of 25 Single-Dose Plastic Fliptop Vials NDC 0404-9959-20 1 20 mL Single-Dose Plastic Fliptop Vial in a bag (Vial bears NDC 0409-4887-23) 20 mL NDC 0409-4887-50 Tray of 25 Single-Dose Plastic Fliptop Vials NDC 0404-9959-50 1 50 mL Single-Dose Plastic Fliptop Vial in a bag (Vial bears NDC 0409-4887-24) 50 mL Distributed by Hospira, Inc., Lake Forest, IL 60045 USA LAB-1292-2.0 Revised: 05/2021 Image1.jpg
Adverse event reports
Source: openFDA FAERSAttributed to this product's most-reported active ingredient: WATER. Combination products with more than six active ingredients are not attributed, because a report count summed across a long ingredient list measures the list, not the medicine.
Recalls
Source: FDA Enforcement| Classification | Reported | Firm | Reason | Status |
|---|---|---|---|---|
| Class II | April 29, 2026 | B BRAUN MEDICAL INC | Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed. | Ongoing |
| Class II | September 24, 2025 | B BRAUN MEDICAL INC | Lack of Assurance of Sterility- Potential for fluid leakage from the port due to port misalignment. | Ongoing |
| Class II | March 8, 2023 | Nephron Sc Inc | CGMP Deviations: Potential product carryover. | Terminated |
| Class II | February 1, 2023 | Nephron Sc Inc | CGMP Deviations: potential for trace amounts of product carryover. | Terminated |
| Class II | May 26, 2021 | Pfizer Inc. | Presence of Particulate Matter: particulate matter identified as an insect in one vial. | Terminated |
Shortages
Source: FDA Drug Shortages| Status | Availability | Company | Presentation | Updated |
|---|---|---|---|---|
| Current | Available | Hospira, Inc., a Pfizer Company | Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-99) | September 22, 2026 |
| Current | Available | Hospira, Inc., a Pfizer Company | Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-50) | September 22, 2026 |
| Current | Available | B. Braun Medical Inc. | Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0264-2101-00) | September 22, 2026 |
| Current | Available | Hospira, Inc., a Pfizer Company | Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-20) | September 22, 2026 |
| Current | Available | Hospira, Inc., a Pfizer Company | Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-10) | September 22, 2026 |
| Current | Available | B. Braun Medical Inc. | Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0264-2101-10) | September 22, 2026 |
| Current | Available | Hikma Pharmaceuticals USA, Inc. | Sterile Water, Injection, 1 mL/1 mL (NDC 0641-6147-10) | September 18, 2026 |
| Current | Available | Baxter Healthcare | Sterile Water, Irrigant, 100 mL/100 mL (NDC 0338-0004-02) | September 17, 2026 |
| Current | Available | Baxter Healthcare | Sterile Water, Irrigant, 100 mL/100 mL (NDC 0338-0004-03) | September 17, 2026 |
| Current | Limited Availability | Baxter Healthcare | Sterile Water, Irrigant, 100 mL/100 mL (NDC 0338-0004-04) | September 17, 2026 |
| Current | Available | Medefil, Inc. | Sterile Water, Injection, 10 mL/10 mL (NDC 64253-020-30) | September 15, 2026 |
| Current | Available | Fresenius Kabi USA, LLC | Sterile Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 63323-185-50) | September 15, 2026 |
| Current | Unavailable | Fresenius Kabi USA, LLC | Sterile Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 63323-185-10) | September 15, 2026 |
| Current | Available | Fresenius Kabi USA, LLC | Sterile Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 63323-185-20) | September 15, 2026 |
| Current | Available | Fresenius Kabi USA, LLC | Sterile Water, Injection, 1000 mL/1000 mL (NDC 63323-178-76) | September 15, 2026 |
| Current | Limited Availability | Nephron Pharmaceuticals Corporation | Sterile Water, Injection, 1 mL/1 mL (NDC 0487-6105-01) | August 4, 2026 |
Packaging and NDCs
Source: NDC Directory| Package NDC | Product NDC | Labeler | Description | Marketing start |
|---|---|---|---|---|
| 50090-2874-1 | 50090-2874 | A-S Medication Solutions | 25 VIAL, PLASTIC in 1 TRAY (50090-2874-1) / 10 mL in 1 VIAL, PLASTIC | February 17, 2017 |
| 76420-082-10 | 76420-082 | Asclemed USA, Inc. | 10 mL in 1 VIAL, PLASTIC (76420-082-10) | April 9, 2020 |
| 0264-7385-50 | 0264-7385 | B. Braun Medical Inc. | 4 CONTAINER in 1 CASE (0264-7385-50) / 2000 mL in 1 CONTAINER | September 4, 2014 |
| 0264-7385-60 | 0264-7385 | B. Braun Medical Inc. | 4 CONTAINER in 1 CASE (0264-7385-60) / 3000 mL in 1 CONTAINER | September 4, 2014 |
| 0264-7850-00 | 0264-7850 | B. Braun Medical Inc. | 12 CONTAINER in 1 CASE (0264-7850-00) / 1000 mL in 1 CONTAINER | February 24, 1988 |
| 0264-7850-10 | 0264-7850 | B. Braun Medical Inc. | 24 CONTAINER in 1 CASE (0264-7850-10) / 500 mL in 1 CONTAINER | February 24, 1988 |
| 0264-7850-20 | 0264-7850 | B. Braun Medical Inc. | 24 CONTAINER in 1 CASE (0264-7850-20) / 250 mL in 1 CONTAINER | February 24, 1988 |
| 17271-802-07 | 17271-802 | Becton Dickinson and Company | 6 BAG in 1 CASE (17271-802-07) / 1000 mL in 1 BAG | January 2, 2026 |
| 17271-802-08 | 17271-802 | Becton Dickinson and Company | 5 BAG in 1 CASE (17271-802-08) / 2000 mL in 1 BAG | January 2, 2026 |
| 17271-802-09 | 17271-802 | Becton Dickinson and Company | 4 BAG in 1 CASE (17271-802-09) / 3000 mL in 1 BAG | November 14, 2025 |
| 55154-0127-5 | 55154-0127 | Cardinal Health 107, LLC | 5 VIAL, PLASTIC in 1 BAG (55154-0127-5) / 10 mL in 1 VIAL, PLASTIC | September 15, 2011 |
| 55154-9588-5 | 55154-9588 | Cardinal Health 107, LLC | 5 VIAL in 1 BAG (55154-9588-5) / 10 mL in 1 VIAL | October 31, 2024 |
| 62135-833-84 | 62135-833 | Chartwell RX, LLC | 30 VIAL, SINGLE-DOSE in 1 CARTON (62135-833-84) / 5 mL in 1 VIAL, SINGLE-DOSE | January 25, 2024 |
| 63323-185-05 | 63323-185 | Fresenius Kabi USA, LLC | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-185-05) / 5 mL in 1 VIAL, SINGLE-DOSE (63323-185-04) | April 30, 2022 |
| 63323-185-10 | 63323-185 | Fresenius Kabi USA, LLC | 25 VIAL in 1 TRAY (63323-185-10) / 10 mL in 1 VIAL (63323-185-07) | September 5, 2000 |
| 63323-185-20 | 63323-185 | Fresenius Kabi USA, LLC | 25 VIAL in 1 TRAY (63323-185-20) / 20 mL in 1 VIAL (63323-185-08) | September 5, 2000 |
| 63323-185-50 | 63323-185 | Fresenius Kabi USA, LLC | 25 VIAL in 1 TRAY (63323-185-50) / 50 mL in 1 VIAL (63323-185-09) | September 5, 2000 |
| 65219-187-10 | 65219-187 | Fresenius Kabi USA, LLC | 25 VIAL, SINGLE-DOSE in 1 TRAY (65219-187-10) / 100 mL in 1 VIAL, SINGLE-DOSE (65219-187-01) | April 29, 2022 |
| 65219-495-10 | 65219-495 | Fresenius Kabi USA, LLC | 6 BAG in 1 CASE (65219-495-10) / 1000 mL in 1 BAG (65219-495-01) | December 19, 2025 |
| 65219-497-20 | 65219-497 | Fresenius Kabi USA, LLC | 5 BAG in 1 CASE (65219-497-20) / 2000 mL in 1 BAG (65219-497-02) | December 19, 2025 |
| 65219-499-30 | 65219-499 | Fresenius Kabi USA, LLC | 4 BAG in 1 CASE (65219-499-30) / 3000 mL in 1 BAG (65219-499-03) | March 3, 2025 |
| 51662-1265-1 | 51662-1265 | HF Acquisition Co LLC, DBA HealthFirst | 50 mL in 1 VIAL, PLASTIC (51662-1265-1) | September 17, 2018 |
| 51662-1329-1 | 51662-1329 | HF Acquisition Co LLC, DBA HealthFirst | 10 mL in 1 VIAL, PLASTIC (51662-1329-1) | October 8, 2018 |
| 51662-1474-1 | 51662-1474 | HF Acquisition Co LLC, DBA HealthFirst | 20 mL in 1 VIAL, PLASTIC (51662-1474-1) | December 14, 2019 |
| 51662-1266-1 | 51662-1266 | HF Acquisition Co. LLC, DBA HealthFirst | 100 mL in 1 VIAL, GLASS (51662-1266-1) | September 2, 2018 |
| 0404-9959-10 | 0404-9959 | Henry Schein, Inc. | 1 VIAL, SINGLE-DOSE in 1 BAG (0404-9959-10) / 10 mL in 1 VIAL, SINGLE-DOSE | January 12, 2022 |
| 0404-9959-20 | 0404-9959 | Henry Schein, Inc. | 1 VIAL, SINGLE-DOSE in 1 BAG (0404-9959-20) / 20 mL in 1 VIAL, SINGLE-DOSE | January 12, 2022 |
| 0404-9959-50 | 0404-9959 | Henry Schein, Inc. | 1 VIAL, SINGLE-DOSE in 1 BAG (0404-9959-50) / 50 mL in 1 VIAL, SINGLE-DOSE | January 12, 2022 |
| 0404-9971-00 | 0404-9971 | Henry Schein, Inc. | 1 VIAL, GLASS in 1 BAG (0404-9971-00) / 100 mL in 1 VIAL, GLASS | January 10, 2022 |
| 0409-0024-10 | 0409-0024 | Hospira, Inc. | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-0024-10) / 10 mL in 1 VIAL, SINGLE-DOSE (0409-0024-01) | March 31, 2025 |
| 0409-4887-10 | 0409-4887 | Hospira, Inc. | 25 VIAL, PLASTIC in 1 TRAY (0409-4887-10) / 10 mL in 1 VIAL, PLASTIC (0409-4887-17) | August 1, 2005 |
| 0409-4887-20 | 0409-4887 | Hospira, Inc. | 25 VIAL, PLASTIC in 1 TRAY (0409-4887-20) / 20 mL in 1 VIAL, PLASTIC (0409-4887-23) | June 16, 2005 |
| 0409-4887-34 | 0409-4887 | Hospira, Inc. | 30 VIAL, PLASTIC in 1 TRAY (0409-4887-34) / 10 mL in 1 VIAL, PLASTIC (0409-4887-32) | July 30, 2015 |
| 0409-4887-50 | 0409-4887 | Hospira, Inc. | 25 VIAL, PLASTIC in 1 TRAY (0409-4887-50) / 50 mL in 1 VIAL, PLASTIC (0409-4887-24) | August 4, 2005 |
| 0409-4887-99 | 0409-4887 | Hospira, Inc. | 25 VIAL, GLASS in 1 CASE (0409-4887-99) / 100 mL in 1 VIAL, GLASS (0409-4887-25) | August 3, 2005 |
| 71872-7290-1 | 71872-7290 | Medical Purchasing Solutions, LLC | 1 VIAL, PLASTIC in 1 BAG (71872-7290-1) / 20 mL in 1 VIAL, PLASTIC | June 3, 2022 |
| 0487-6105-01 | 0487-6105 | Nephron Pharmaceuticals Corporation | 30 VIAL, PLASTIC in 1 CARTON (0487-6105-01) / 5 mL in 1 VIAL, PLASTIC | June 16, 2021 |
| 84549-850-10 | 84549-850 | ProPharma Distribution | 500 mL in 1 CONTAINER (84549-850-10) | September 18, 2025 |
| 84549-887-50 | 84549-887 | ProPharma Distribution | 50 mL in 1 VIAL, PLASTIC (84549-887-50) | August 27, 2025 |
| 70518-4732-1 | 70518-4732 | REMEDYREPACK INC. | 25 VIAL, PLASTIC in 1 TRAY (70518-4732-1) / 10 mL in 1 VIAL, PLASTIC (70518-4732-0) | August 23, 2026 |
| 50090-2874 | 50090-2874 | A-S Medication Solutions | — | June 16, 2005 |
| 76420-082 | 76420-082 | Asclemed USA, Inc. | — | June 16, 2005 |
| 0264-7385 | 0264-7385 | B. Braun Medical Inc. | — | September 4, 2014 |
| 0264-7850 | 0264-7850 | B. Braun Medical Inc. | — | February 24, 1988 |
| 17271-802 | 17271-802 | Becton Dickinson and Company | — | November 14, 2025 |
| 55154-0127 | 55154-0127 | Cardinal Health 107, LLC | — | September 15, 2011 |
| 55154-9588 | 55154-9588 | Cardinal Health 107, LLC | — | October 31, 2024 |
| 62135-833 | 62135-833 | Chartwell RX, LLC | — | June 7, 2021 |
| 63323-185 | 63323-185 | Fresenius Kabi USA, LLC | — | September 5, 2000 |
| 65219-187 | 65219-187 | Fresenius Kabi USA, LLC | — | April 29, 2022 |
| 65219-495 | 65219-495 | Fresenius Kabi USA, LLC | — | December 19, 2025 |
| 65219-497 | 65219-497 | Fresenius Kabi USA, LLC | — | December 19, 2025 |
| 65219-499 | 65219-499 | Fresenius Kabi USA, LLC | — | March 3, 2025 |
| 51662-1265 | 51662-1265 | HF Acquisition Co LLC, DBA HealthFirst | — | September 17, 2018 |
| 51662-1329 | 51662-1329 | HF Acquisition Co LLC, DBA HealthFirst | — | October 8, 2018 |
| 51662-1474 | 51662-1474 | HF Acquisition Co LLC, DBA HealthFirst | — | December 14, 2019 |
| 51662-1266 | 51662-1266 | HF Acquisition Co. LLC, DBA HealthFirst | — | September 2, 2018 |
| 0404-9959 | 0404-9959 | Henry Schein, Inc. | — | January 12, 2022 |
| 0404-9971 | 0404-9971 | Henry Schein, Inc. | — | January 10, 2022 |
| 0409-0024 | 0409-0024 | Hospira, Inc. | — | March 31, 2025 |
| 0409-4887 | 0409-4887 | Hospira, Inc. | — | June 16, 2005 |
| 71872-7290 | 71872-7290 | Medical Purchasing Solutions, LLC | — | June 16, 2005 |
| 0487-6105 | 0487-6105 | Nephron Pharmaceuticals Corporation | — | June 7, 2021 |
| 84549-850 | 84549-850 | ProPharma Distribution | — | February 24, 1988 |
| 84549-887 | 84549-887 | ProPharma Distribution | — | June 16, 2005 |
| 70518-4732 | 70518-4732 | REMEDYREPACK INC. | — | August 23, 2026 |
Sources for this page
| Dataset | Agency | Used for |
|---|---|---|
| NDC Directory | FDA | Identity, ingredients, strengths, forms, routes, labelers, packages |
| Drugs@FDA | FDA | Application, sponsor, submissions, review documents, marketing status |
| Orange Book | FDA | Therapeutic equivalence codes, reference drug flags, patents, exclusivity |
| Drug Labeling | FDA / NLM | Prescribing information reproduced above |
| FAERS | FDA | Adverse event report counts |
| Enforcement | FDA | Recall records |
| Drug Shortages | FDA | Supply availability |
Generated September 25, 2026 · 13 sections on this page.